Lahousen M
Geburtshilfliche Gynäkologische Universitäts-Klinik Graz.
Arch Gynecol Obstet. 1989;245(1-4):517-23. doi: 10.1007/BF02417402.
Between 1970 and 1982, 113 patients were treated for invasive vulvar cancer in FIGO stages I-IV; 97 patients were available for follow-up. Forty-one patients (42.3%) underwent radical vulvectomy and lymphadenectomy, 21 underwent simple vulvectomy, and 12 (12.4%) had electric resection of the lesion; 42 patients (43.3%) received postoperative radiotherapy. The 5-year survival rate was 61.8% after surgery and radiotherapy. Five-year survival in stages I, II, and III was 85.3%, 60.7%, and 17.9%, respectively. Overall 5-year survival was 52.6%. Patients with small, highly differentiated squamous cell cancers, without lymph node involvement, did best.
1970年至1982年间,113例FIGO I-IV期浸润性外阴癌患者接受了治疗;97例患者可供随访。41例患者(42.3%)接受了根治性外阴切除术及淋巴结清扫术,21例接受了单纯外阴切除术,12例(12.4%)进行了病变的电切除术;42例患者(43.3%)接受了术后放疗。手术及放疗后的5年生存率为61.8%。I期、II期和III期的5年生存率分别为85.3%、60.7%和17.9%。总体5年生存率为52.6%。肿瘤小、高分化、无淋巴结转移的鳞状细胞癌患者预后最佳。